KIMBERLY KIRTON: Open Payments
NPI 1104808013 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,616 in 140 payments from 25 companies in 2025. Trend: 2023 $1,648 · 2024 $2,597 · 2025 $3,616
Food & beverage: $3,595Education: $20
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 18 | $580 |
| Boston Scientific Corporation | 11 | $421 |
| PFIZER INC. | 17 | $334 |
| Novo Nordisk Inc | 5 | $210 |
| BridgeBio Pharma, Inc. | 7 | $198 |
| AstraZeneca Pharmaceuticals LP | 8 | $190 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $189 |
| Alnylam Pharmaceuticals Inc. | 8 | $168 |
| Novartis Pharmaceuticals Corporation | 17 | $161 |
| Amgen Inc. | 5 | $151 |
Products named: Kerendia, VYNDAQEL, WATCHMAN FLX, Attruby, Wegovy, ONPATTRO, LEQVIO, REPATHA.
Industry payments across SC — which companies pay providers there.
